Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIS-ISD: Impact of Salt Intake on Skin Sodium and Inflammatory Skin Disease
NCT07487831Phase 4Recruiting
- Sponsor
- University of California, San Francisco
- Start
- Jul 2026
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
Phase 4, randomised trial of sodium chloride in atopic dermatitis (AD) and psoriasis (2 arms), sponsored by University of California, San Francisco. Primary endpoints: Fidelity of low-salt diet at 4 months, Feasibility measured by recruitment rates and exclusion and non-participation reasons at 4 months and 1 more. Started Jul 2026; status: recruiting.
02
Drugs
sodium chloride
03
Conditions
atopic dermatitis (AD)psoriasis
Beyond the preview
Go deeper on NCT07487831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07487831.